Amerilab Technologies — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Amerilab Technologies is a private, revenue-generating CDMO that has carved out a niche as a specialist in effervescent and powder-based drug and supplement delivery. Its core value proposition lies in its deep technical expertise, patented formulations for rapid disintegration and clean-label ingredients, and flexible, automated packaging capabilities. The company, now part of the larger HBI Health & Beauty Innovations and the Ourvita Group, leverages its specialized manufacturing platform to serve clients seeking innovative, consumer-friendly oral solid dosage forms.

Drug Delivery

Technology Platform

Proprietary effervescent formulation platform utilizing crystalline sugar binders for rapid disintegration and clean-label profiles, supported by specialized development and automated multi-flavor stick/pouch manufacturing capabilities.

Opportunities

Growing consumer demand for convenient, tasty, and clean-label supplement and OTC drug formats drives the effervescent and powder market.

Integration into the Ourvita Group provides access to European markets and expanded client networks.

Investment in flexible, automated packaging (like multi-flavor sticks) meets demand for personalized and variety-driven product offerings.

Risk Factors

Revenue is dependent on a contract-based model, creating client concentration and project pipeline risks.

Operating in a highly regulated (FDA cGMP) environment for ingestible products exposes the company to compliance and quality failure risks.

Competition from other CDMOs and potential raw material supply chain disruptions pose ongoing operational and margin challenges.

Competitive Landscape

Amerilab competes in the niche CDMO space for effervescent and powder dosage forms. It differentiates itself through deep, patented formulation expertise and specialized, automated packaging solutions. Key competitors include other specialized powder/effervescent manufacturers and larger, diversified CDMOs that offer similar services as part of a broader portfolio.

More companies in Drug Delivery & Formulation →More companies in United States →